Bone Marrow Stromal Antigen 2 Is a Novel Plasma Biomarker and Prognosticator for Colorectal Carcinoma: A Secretome-Based Verification Study

<div>Overexpression of BST2 in CRC tissues. (a) The representative pictures of immunohistochemical staining patterns of BST2 in four pairs of tumor (T) and adjacent normal counterpart (AN) sections (scale bar = 200 <i>μ</i>m). (b) Analysis of the IHC scores of BST2 in 132 CRC tissue specimens harboring both tumor and adjacent normal counterpart. T-AN: the difference of IHC score between paired T and AN.</div>

Disease Markers

fig2

Figure 2

Figure 2: Bone Marrow Stromal Antigen 2 Is a Novel Plasma Biomarker and Prognosticator for Colorectal Carcinoma: A Secretome-Based Verification Study 

Figure 2 | Bone Marrow Stromal Antigen 2 Is a Novel Plasma Biomarker and Prognosticator for Colorectal Carcinoma: A Secretome-Based Verification Study 